NMPA accepts clinical trial application for monkeypox vaccine

chinadaily.com.cn | Updated: 2023-07-14 19:44

Share - WeChat

The National Medical Products Administration (NMPA) has, on Thursday, officially accepted the clinical trial application for the replication-deficient monkeypox vaccine developed by China National Pharmaceutical Group Corporation (Sinopharm) Beijing Institute of Biological Products.

Photo

Ten photos from across China: Sept 5 – Sept 11

Jianjiangyan irrigation system added to world heritage list

China releases details of Huangyan Island nature reserve

Vitality of Samawar dance in Xinjiang shines in hustle and bustle of daily life

Ancient irrigation systems earn recognition

Tiger and lion cubs debut at Chongqing park event

Latest

State Council News

China to launch K visa for young science, technology talents

Exclusive

Olympic champion Zhang Yufei voices for climate action?

One-China principle: From the UN to global consensus

People's call for reunion

Newsmaker

Naval gunner's attention to detail improves hit rates

Animals get a second chance at life

Ten photos you don't wanna miss

Ten photos from across China: Sept 5 – Sept 11

Special Coverage

Celebrating 70 years of progress in Xinjiang

Stories across the Strait

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.

Registration Number: 130349